arBtrage CAPITALIZING MARKETS checking… Sign in

Prelude Therapeutics Incorporated

PRLD Health Care Biotechnology: Pharmaceutical Preparations
$3.81
▼ -6.6% Today
as of Jun 7, 07:25 ET
Last 30 days -13.21% Apr 28 → Jun 05
$3.36 $3.86 $4.37 $4.87 $5.37 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$4.05
High
$4.06
Low
$3.74
Volume
$219,632
Avg Vol
$591,747
Mkt Cap
$313M
P/E (TTM)
Beta
52w High
$5.54
52w Low
$0.75
Div Yield
Shares Out

Overview

52-week range
$0.75
$5.54
64% of range
Avg surprise (last 2)
+31.2%
Avg reaction (last 2)
-3.2%
0% positive
Latest IV / EM
284%
EM ±39.4% · $5 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.54$-0.44$-0.34$-0.23$-0.13 Actual $-0.54Actual $-0.45Actual $-0.42Actual $-0.46Actual $-0.43Actual $-0.42Est $-0.47Actual $-0.41Actual $-0.26Actual $-0.13Est $-0.27 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-35M$-24M$-14M$-4M$7M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.13 $-0.27 +51.9% +69.0% -3.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.26 financials
Mon Jun 30, 2025Jun 2025 $-0.41 financials
Tue May 6, 2025Mar/2025 $-0.42 $-0.47 +10.6% -3.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.43 financials
Sun Jun 30, 2024Jun 2024 $-0.46 financials
Sun Mar 31, 2024Mar 2024 $-0.42 financials
Sat Sep 30, 2023Sep 2023 $-0.45 financials
Fri Jun 30, 2023Jun 2023 $-0.54 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$5M$6M$0$3M
Cost of revenue
Gross profit
Operating income$-14M$-20M$-32M$-35M$-34M$-37M
Net income$-10M$-20M$-31M$-32M$-32M$-35M
EPS (diluted)$-0.13$-0.26$-0.41$-0.42$-0.43$-0.46

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$22M$35M$48M$26M$40M$12M$11M$28M
Inventory
Total current assets$85M$106M$58M$77M$102M$136M$156M$183M
Total assets$120M$141M$95M$115M$141M$176M$197M$224M
Long-term debt
Total liabilities$59M$73M$36M$39M$38M$44M$41M$42M
Total equity$60M$69M$59M$76M$103M$131M$156M$182M

Implied volatility — last 90 days

279%281%284%286%289% Jun 07 — IV 284% · EM ±39.4%

Sector peers